Navigation Links
NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
Date:3/31/2011

al gains that will allow the pharmaceutical industry to complete higher quality cardiac safety analysis faster, more reliably, and at significantly lower cost."Conference InformationCardiovascular Safety in Drug Development: State-of-the-Art AssessmentsCo-sponsored by FDA, Cardiac Safety Research Consortium, and Heart Rhythm SocietyDate(s) And Time(s): Apr 13 2011 8:00AM - Apr 15 2011 1:00PMLocation: L'Enfant Plaza Hotel 480 L'Enfant Plaza Southwest Washington, DC 20024-0478 About QTinno TechnologyNewCardio's patented QTinno 3-D ECG software technology is a novel, fully automated program for evaluating QT and other timing intervals relevant for assessing drug cardiac toxicity in drug development. It provides fast, accurate and precise QT data from a broad range of challenging ECGs and enables reliable, automated identification of key cardiac events. Pharmaceutical sponsors and clinical research organizations, which are mandated by the FDA to test new drugs for potential cardiac toxicity, are expected to benefit from QTinno's faster, more accurate and less expensive assessment of cardiac status.

About the Cardiac Safety Research ConsortiumThe Cardiac Safety Research Consortium (CSRC) was launched in 2006 under the FDA Critical Path Initiative with the mission of advancing scientific knowledge on cardiac safety for new and existing medical products.  CSRC supports research by engaging stakeholders from industry, academia, and government to share data and expertise. Key objectives include facilitating focused pragmatic research that will inform regulatory processes with regard to cardiac safety, and to develop knowledge and strategies intended to improve the evaluative sciences in relation to cardiac safety and product development.  For more information, visit www.cardiac-safety.org.

About
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NewCardio Announces Positive Results From Third Clinical Validation Study
2. Vincent W. Renz Joins NewCardio as President
3. NewCardio Leadership to Present Two Abstracts at ISCE Conference
4. NewCardio Announces Master Services Agreement With Dedicated Phase I
5. NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit
6. NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress
7. NewCardio CEO Increases Equity Position
8. NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded Testing Dataset
9. NewCardio Announces Financial Results for Its 2010 Third Quarter
10. NewCardios Chief Technical Officer, Dr. Dorin Panescu, Named 2011 IEEE Fellow
11. NewCardio Presents Results for Cardiac Safety Research Consortium Blinded Drug Safety Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented effort to ... TB in ambulances and other transport vehicles, an advanced and portable ... rescue personnel for the first time. In order ... with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
... VIEJO, Calif., Oct. 12, 2011 Avanir Pharmaceuticals, Inc. ... affect (PBA) prevalence data from stroke survivors will be ... Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine in ... details about the data presentation at ACRM/ASNR Progress ...
... Good Start Genetics,™ Inc., an innovative molecular diagnostics ... screening, today announced that it will present results ... next-generation DNA sequencing platform at the Annual Meeting ...  ASRM will be held from October 15-19, 2011 ...
Cached Medicine Technology:Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference 2Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM) 2
(Date:4/23/2014)... from healthy, unrelated donors was safe and effective ... by Clostridium difficile , according to a ... Diseases and available online. Known as fecal ... given via a colonoscope or a nasogastric tube. ... promising treatment more readily available to patients. , ...
(Date:4/23/2014)... John J. O,Shea, M.D., scientific director at the National ... has been named the 2014 recipient of the Ross ... peer-reviewed, open-access journal Molecular Medicine . The award ... York Academy of Sciences in Manhattan, followed by scientific ... is part of the National Institutes of Health. , ...
(Date:4/23/2014)... have developed a way to detect and measure cancer ... particles with tails of synthetic DNA., A team led ... used gold nanoparticles to target and bind to fragments ... variants, which can indicate the presence and stage of ... in a cell can be determined by examining the ...
(Date:4/23/2014)... New Rochelle, NY, April 23, 2014Men whose testosterone falls ... dysfunction and to be overweight and have heart disease ... designed to identify testosterone-deficient men for further testing and ... Journal of Men,s Health , a peer-reviewed publication from ... free on the Journal of Men,s Health ...
(Date:4/23/2014)... As evidence mounts showing the potential health benefits of ... people are taking supplements. And the chemical industry is ... supplements, health effects could deter growth, so the industry ... claims, according to the cover story in Chemical ... of the American Chemical Society. , Melody M. Bomgardner, ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2
... Billion Industry and 12% Growth of Frozen Desserts Nationwide Fuels ... ... Feb. 12 Cefiore, Southern,California-based and one of the nation,s fastest-growing ... for,Valentine,s Day. With more than 90% of U.S. households consuming frozen,desserts ...
... Feb. 12 Peter Ochinko, President of Ft.,Lauderdale-based ... initiative,with top-rated risk assessment software developer RiskWatch, Inc. ... the former Corporate Director,of Security at Memorial Healthcare ... impressive that in 2006, Memorial won the,esteemed Lindberg ...
... Blue Buffalo Foundation for Cancer,Research, http://www.petcancerawareness.com, ... for canine and feline cancer,has made a ... in the,nonprofit,s global effort to cure canine ... Foundation has provided financial sponsorship for two,important ...
... Sheets: CGCP), announced that the company will release,results for ... 2007 prior,to market open on Tuesday, March 4, 2008. ... Senior Vice President and Chief Financial,Officer William R. Abbott ... p.m. Eastern time (9:00 a.m. Pacific time) to review ...
... What do smiling Buddhas,and serious dieters have ... to,fucoPROTEIN bars, they just might lose unwanted pounds. ... America fucoPROTEIN bar, a dietary,supplement that contains fucoxanthin. ... a marine thermogenic that burns fat and boosts,metabolism., ...
... Studies show that only 2 in 5 seek any ... and stress,being one of today,s most common disorders, it ... Mental Health America,organization, leaving more than 40 million people ... feelings of anxiety -- muscle tension,headache, nausea, fatigue, or ...
Cached Medicine News:Health News:Latest Salvo Fired in Frozen Yogurt Wars as Southern California's Fastest-Growing Franchise - Cefiore - Launches New Chocolate Flavor 2Health News:IAS Teams Up with RiskWatch to Offer New Hospital Security and School Security Risk Assessments 2Health News:The Blue Buffalo Foundation for Cancer Research Sponsors Six Morris Animal Foundation Cancer Studies 2Health News:Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th 2Health News:Burn Fat with fucoPROTEIN(TM) Bars 2Health News:40 Million Americans Endure Anxiety Everyday 2
Infusion Cannula, 2.0mm....
Subretinal Fluid Cannula, Curved; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip; Curved at 65°....
Micro Vitreoretinal Cannula; Angled; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 65°, 1mm from Tip....
...
Medicine Products: